Table S1.
Comparison of short-term effects of NACRT in patients with different T stages (T3–T4a vs T4b)
| T3–T4a (N=22) | T4b (N=35) | X2 | P-value | |
|---|---|---|---|---|
| R0 resection | 0.945 | |||
| Yes | 19 (86.4%) | 30 (77.1%) | 0.005 | |
| No | 3 (13.6%) | 5 (14.3%) | ||
| Down T | 0.991 | |||
| Yes | 17 (77.3%) | 27 (77.1%) | 0.000 | |
| No | 5 (22.7%) | 8 (22.9%) | ||
| Downstage | 0.415 | |||
| Yes | 17 (77.3%) | 30 (85.7%) | 0.665 | |
| No | 5 (22.7%) | 5 (14.3%) | ||
| pCR | 0.023* | |||
| Yes | 9 (40.9%) | 5 (14.3%) | 5.168 | |
| No | 13 (59.1%) | 30 (85.7%) |
Note:
*
P<0.05.
Abbreviations: NACRT, neoadjuvant chemoradiotherapy; pCR, pathologic complete response.